TipRanks
Advertisement
Advertisement
Analyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
PremiumRatingsAnalyst Jill Wu Raises Target Price and Reiterates Buy on Innovent Biologics After Strong 1H26 Beat and Robust Growth Outlook
1M ago
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
Premium
Ratings
Jack Lin Reiterates Buy on Innovent Biologics, Citing Strong Profitability, Solid Revenue Growth, and De-Risked Late-Stage Pipeline
1M ago
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
Premium
Company Announcements
Innovent Biologics Reshapes Board Roles as Veteran Executive Retires from Full-Time Post
1M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―